Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hood

Showing results (371-380 of 393) with videos related to

Pageof 40
Sort By:
Nucleic Acids Research|May 24, 2023
Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs)Barbora Malecova, Rob S Burke, Michael Cochran, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 10, 2017
Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regionsJacob S Brenner, Kartik Bhamidipati, Patrick M Glassman, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 15, 2021
Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to NanoparticlesZhicheng Wang, Elizabeth D Hood, Jia Nong, et al.
ACS Nanoscience Au|June 22, 2026
Decoupling Physisorption from Chemisorption in Clickable Lipid NanoparticlesTaylor V Brysgel, Elizabeth D Hood, Aleksa Milosavljevic, et al.
Nature|November 28, 2022
Chiral assemblies of pinwheel superlattices on substratesShan Zhou, Jiahui Li, Jun Lu, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|June 12, 2010
A comparison of the effects of prenatal exposure of CD-1 mice to three imidazolium-based ionic liquidsMelissa M Bailey, Peter L Jernigan, Megan B Henson, et al.
Cell Host & Microbe|February 2, 2010
A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteriaRachel D Hood, Pragya Singh, Fosheng Hsu, et al.
Blood|May 16, 2008
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemiaIlaria V Libani, Ella C Guy, Luca Melchiori, et al.
ACS Nano|March 10, 2022
Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular NanocarriersLaura T Ferguson, Elizabeth D Hood, Tea Shuvaeva, et al.
Cancer Cell|April 9, 2008
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia veraGerlinde Wernig, Michael G Kharas, Rachel Okabe, et al.
Pageof 40

Showing results (371-380 of 393) with videos related to

Sort By:
Pageof 40
Nucleic Acids Research|May 24, 2023
Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs)Barbora Malecova, Rob S Burke, Michael Cochran, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 10, 2017
Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regionsJacob S Brenner, Kartik Bhamidipati, Patrick M Glassman, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 15, 2021
Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to NanoparticlesZhicheng Wang, Elizabeth D Hood, Jia Nong, et al.
ACS Nanoscience Au|June 22, 2026
Decoupling Physisorption from Chemisorption in Clickable Lipid NanoparticlesTaylor V Brysgel, Elizabeth D Hood, Aleksa Milosavljevic, et al.
Nature|November 28, 2022
Chiral assemblies of pinwheel superlattices on substratesShan Zhou, Jiahui Li, Jun Lu, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|June 12, 2010
A comparison of the effects of prenatal exposure of CD-1 mice to three imidazolium-based ionic liquidsMelissa M Bailey, Peter L Jernigan, Megan B Henson, et al.
Cell Host & Microbe|February 2, 2010
A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteriaRachel D Hood, Pragya Singh, Fosheng Hsu, et al.
Blood|May 16, 2008
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemiaIlaria V Libani, Ella C Guy, Luca Melchiori, et al.
ACS Nano|March 10, 2022
Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular NanocarriersLaura T Ferguson, Elizabeth D Hood, Tea Shuvaeva, et al.
Cancer Cell|April 9, 2008
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia veraGerlinde Wernig, Michael G Kharas, Rachel Okabe, et al.
Pageof 40